Brian Hosung Min | Vice President
Samsung

Brian Hosung Min is currently Vice President of Strategic Business Development at Samsung Group. He is in charge of biosimilar process development and business development for antibody manufacturing and biosimilars. Before moving to this position, he was the Head of Antibody Engineering at Samsung, in charge of developing novel antibody-based therapeutic platform and antibody biosimilar development. Before joining Samsung in 2008, Dr. Min was a Principal Scientist at Amgen for over 10 years in charge of engineering all phage-display based protein therapeutics and developing multiple protein therapeutics that are currently in clinical trials. He holds a B.A. from University of California, Berkeley and a Ph.D. from University of California, LosAngeles. Experience 2011~Present Vice President, Strategic Business Development, Samsung, Korea 2008~2011 Head of Antibody Engineering, Samsung, Korea 1997~2007 Principal Scientist, Amgen, Thousand Oaks, CA Education and Training 1992~1997 PhD in Molecular Biology, University of California, Los Angeles, USA 1987~1991 BA in Molecular Biology, University of California, Berkeley, USA